ArticleBioMedicine2025
Neurenteric cysts: A neurosurgical case series and treatment perspectives.
Article in BioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurenteric cysts (NC) are rare lesions of endodermal origin lined by mucin-secreting cuboidal or columnar epithelium of an intestinal or respiratory type. They occur more frequently in the spinal cord than in the cranium. From the radiological view, NC may be confused with other lesions of the central nervous system, like arachnoid or epidermoid cysts. However, due to advances in neuroimaging, there is an increasing trend in preoperative diagnosis of NC. We are reporting three cases of NC, each exhibiting markedly distinct symptoms and postoperative courses. The first patient, a 45-year-old woman, had NC in the fourth ventricle. Although she underwent surgery, the lesion recurred 55 months later. The second patient, a 66-year-old woman, had NC in the left cerebellopontine angle. After partial removal, the remaining cyst maintained its size for 94 months. The third patient, a 55-year-old man, presented with NC close to the medullary cone. Despite tumor reduction, a hemorrhagic cyst developed 41 months later, which was accompanied by increased lumbosacral pain. A review of knowledge of current treatment strategies and challenges of NC is discussed. Surgical intervention is the primary therapeutic approach for patients with NC, particularly those experiencing symptoms. The primary challenge in treating NC is preventing cyst recurrence. The complete resection of NC is critical for minimizing the probability of cyst recurrence. Continuous lifelong follow-up is essential, as NC recurrences can occur even after decades.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.